February 2026 – Dubai, UAE
Landing Med successfully participated in WHX Labs Dubai 2026, one of the region’s premier laboratory and diagnostics events, where the company presented its latest advancements in digital pathology and AI-powered cervical cytology solutions.
At the exhibition, Landing Med highlighted its AI cervical cytology system, designed to enhance screening efficiency, alongside the newly released LD Patho 340A compact digital pathology slide scanner. Together, these solutions demonstrate Landing Med’s commitment to making high-quality digital pathology more accessible to laboratories of all sizes.
The LD Patho 340A drew particular attention for its compact design, ease of use, and performance capabilities—making it an ideal entry point for laboratories beginning their transition to digital workflows. Meanwhile, the AI cervical cytology system showcased the potential of artificial intelligence to streamline routine screening processes while supporting clinical decision-making.
Throughout the event, Landing Med engaged with a wide range of industry professionals, including pathologists, laboratory managers, and technicians from across the Middle East, Africa, and beyond. Both solutions received highly positive feedback, with visitors highlighting their practicality, efficiency, and strong potential to improve laboratory operations.
“We are encouraged by the enthusiastic response from the pathology community at WHX Labs Dubai,” said Lan Wang, Head of Global Marketing. “It reinforces the growing demand for lab digitization, telepathology, and accessible, easy-to-use solutions.”
Landing Med’s participation at WHX Labs Dubai 2026 marks another step forward in expanding its global presence and strengthening partnerships in key international markets. The company looks forward to continuing its collaboration with healthcare providers and laboratories worldwide to advance innovation in pathology and diagnostics.
fr 
es 
CN
